Evidence map›Paper›PMID 25339905›Full record

ArticleFrontiers in pharmacology2014

The contribution of cell surface FcRn in monoclonal antibody serum uptake from the intestine in suckling rat pups.

Philip R Cooper, Connie M Kliwinski, Robert A Perkinson, Edwin Ragwan, John R Mabus, Gordon D Powers, Haimanti Dorai, Jill Giles-Komar, Pamela J Hornby

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Philip R CooperBiologics Research, Janssen R&D - Johnson & Johnson, Biotechnology Center of Excellence Spring House, PA, USA.
Connie M KliwinskiBiologics Pharmacology and Toxicology, Janssen R&D - Johnson & Johnson, Biotechnology Center of Excellence Spring House, PA, USA.
Robert A PerkinsonBiologics Research, Janssen R&D - Johnson & Johnson, Biotechnology Center of Excellence Spring House, PA, USA.
Edwin RagwanBiologics Research, Janssen R&D - Johnson & Johnson, Biotechnology Center of Excellence Spring House, PA, USA.
John R MabusBiologics Research, Janssen R&D - Johnson & Johnson, Biotechnology Center of Excellence Spring House, PA, USA.
Gordon D PowersBiologics Research, Janssen R&D - Johnson & Johnson, Biotechnology Center of Excellence Spring House, PA, USA.
Haimanti DoraiBiologics Research, Janssen R&D - Johnson & Johnson, Biotechnology Center of Excellence Spring House, PA, USA.
Jill Giles-KomarBiologics Research, Janssen R&D - Johnson & Johnson, Biotechnology Center of Excellence Spring House, PA, USA.
Pamela J HornbyBiologics Research, Janssen R&D - Johnson & Johnson, Biotechnology Center of Excellence Spring House, PA, USA.
Janssen (United States) · USJohnson & Johnson (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The neonatal Fc receptor (FcRn) in intestinal epithelium is the primary mechanism for transfer of maternal immunoglobulin G (IgG) from suckled milk to serum; but the factors contributing to the rapid uptake of IgG are poorly understood. These studies help to determine the contribution of cell surface FcRn in IgG uptake in 2-week-old rat pups by varying local pH and binding conditions. Variants of a human wild-type (WT) IgG monoclonal antibody (mAb WT) were assessed for binding affinity (KD) to rat (r)FcRn at pH 6.0 and subsequent off-rate at pH 7.4 (1/s) by surface plasmon resonance. Selected mAbs were administered intra-intestinally in isoflurane-anesthetized 2-week rat pups. Full length mAb in serum was quantified by immunoassay, (r)FcRn mRNA expression by reverse transcription polymerase chain reaction, and mAb epithelial localization was visualized by immunohistochemistry. After duodenal administration, serum levels of mAb variants correlated with their rFcRn off-rate at pH 7.4, but not their affinity at pH 6.0. The greatest serum levels of IgG were measured when mAb was administered in the duodenum where rFcRn mRNA expression is greatest, and was increased further by duodenal administration in pH 6.0 buffer. More intense human IgG immunostaining was detected in epithelium than the same variant administered at higher pH. These data suggest an increased contribution for cell surface receptor. We conclude that, in the neonate duodenum, receptor off-rates are as important as affinities for FcRn mediated uptake, and cell surface binding of IgG to rFcRn plays contributes to IgG uptake alongside pinocytosis; both of which responsible for increased IgG uptake.

Indexed as

bioavailabilitycell surface receptorFcRnIgGuptake

Identifiers

PMID25339905
PMCPMC4188031
OpenAlexW1965913823

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.